Hizentra

Made by

• CSL Behring

Active Ingredient

pH4 Treated human normal immunoglobulin

Approval date

2013/9/27

Treats

• Kawasaki disease, Mucocutaneous lymph node syndrome
• Chronic inflammatory demyelinating polyradiculoneuropathy
• Agammaglobulinemias
• Immune thrombocytopenia, Autoimmune thrombocytopenic purpura

Dosages

• Hizentra 20％ S.C.Injection 1g/5mL - 8831円／瓶

• Hizentra 20％ S.C.Injection 2g/10mL - 16930円／瓶

• Hizentra 20％ S.C.Injection 4g/20mL - 31591円／瓶